Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain User HealthEconBot, in the Health Economics Journal Articles subreddit, 18 Oct 2017